AbbVie Price
227.73₺ %1.32+2.96
Last update:
High228.40 ₺
Low224.32 ₺
Volume4.01M
Market Cap402.35B
52W Low: 181.7319.32%52W High: 244.81
After-Hours227.25-0.21%
- Open
- 227.50
- P/E
- 111.09
- Forward P/E
- 14.01
- P/B
- -60.45
- EPS (TTM)
- 2.05
- Forward EPS
- 16.2556
- Book Value
- -3.767
- Dividend Yield
- 3.00% (6.74)
- Dividend Date
- May 15, 2026
- 50-Day Avg
- 210.8038
- 200-Day Avg
- 220.3501
- Avg Volume (3M)
- 6.42M
- Shares Outstanding
- 1.77B
- Bid / Ask
- 225.85 / 227.71
- Analyst Rating
- 1.8 - Buy
- Next Earnings
- Apr 29, 2026
- Exchange
- NYSE
- Market State
- Closed
Company Data
Healthcare · Drug Manufacturers - General · 57000 employees
| Forward P/E | 14.01 |
|---|---|
| PEG Ratio | 0.63 |
| Beta | 0.31 |
| Earnings Per Share (EPS) | 2.05 |
| 52-Week Change | %19.32 |
| Enterprise Value (EV) | 465.9B |
| Shares Outstanding | 1.8B |
| Last Dividend | 1.73 (April 15, 2026) |
| Insider Ownership | %0.11 |
| Institutional Ownership | %76.89 |
| Net Profit Margin | %5.79 |
|---|---|
| Operating Margin | %32.16 |
| Return on Assets (ROA) | %10.03 |
| Revenue Growth | %12.4 |
| Earnings Growth | %-46.2 |
| Current Ratio | 0.8 |
Analyst Outlook
- Average Price Target
- 253.55
- Target Range
- 184 – 328
- Number of Analysts
- 29
- Consensus
- Buy
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 8 | 16 | 8 | 0 | 0 |
Company data is sourced from Yahoo Finance and may be delayed; this is not investment advice.
AbbVie News
- AbbVie (ABBV) Rises Higher Than Market: Key Facts
- AbbVie (ABBV) Stock Weighs DCF Upside Against Elevated P/E At US$227.73
- Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years
- 3 Ridiculously Cheap Healthcare Stocks to Buy in June
- AbbVie Says Leukemia Combination Therapy Shows Long-Term benefit Phase 3 study
- AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
News is sourced from Yahoo Finance; headlines link to external sources.
What Is AbbVie?
AbbVie (ABBV) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for AbbVie. Data is updated during Borsa İstanbul session hours.
The AbbVie price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the AbbVie Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is AbbVie?
- AbbVie (ABBV) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "ABBV".
- What are the AbbVie trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the AbbVie price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for AbbVie occur?
- AbbVie dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.